These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 20825972

  • 1. Expression of ribonucleotide reductase M2 subunit in gastric cancer and effects of RRM2 inhibition in vitro.
    Morikawa T, Hino R, Uozaki H, Maeda D, Ushiku T, Shinozaki A, Sakatani T, Fukayama M.
    Hum Pathol; 2010 Dec; 41(12):1742-8. PubMed ID: 20825972
    [Abstract] [Full Text] [Related]

  • 2. Metastasis-suppressing potential of ribonucleotide reductase small subunit p53R2 in human cancer cells.
    Liu X, Zhou B, Xue L, Shih J, Tye K, Lin W, Qi C, Chu P, Un F, Wen W, Yen Y.
    Clin Cancer Res; 2006 Nov 01; 12(21):6337-44. PubMed ID: 17085643
    [Abstract] [Full Text] [Related]

  • 3. Ribonucleotide reductase M2 subunit is a novel diagnostic marker and a potential therapeutic target in bladder cancer.
    Morikawa T, Maeda D, Kume H, Homma Y, Fukayama M.
    Histopathology; 2010 Dec 01; 57(6):885-92. PubMed ID: 21166702
    [Abstract] [Full Text] [Related]

  • 4. Ribonucleotide reductase subunits M2 and p53R2 are potential biomarkers for metastasis of colon cancer.
    Liu X, Zhou B, Xue L, Yen F, Chu P, Un F, Yen Y.
    Clin Colorectal Cancer; 2007 Jan 01; 6(5):374-81. PubMed ID: 17311703
    [Abstract] [Full Text] [Related]

  • 5. Targeting ribonucleotide reductase M2 subunit by small interfering RNA exerts anti-oncogenic effects in gastric adenocarcinoma.
    Kang W, Tong JH, Chan AW, Zhao J, Wang S, Dong Y, Sin FM, Yeung S, Cheng AS, Yu J, To K.
    Oncol Rep; 2014 Jun 01; 31(6):2579-86. PubMed ID: 24756820
    [Abstract] [Full Text] [Related]

  • 6. RRM2 induces NF-kappaB-dependent MMP-9 activation and enhances cellular invasiveness.
    Duxbury MS, Whang EE.
    Biochem Biophys Res Commun; 2007 Mar 02; 354(1):190-6. PubMed ID: 17222798
    [Abstract] [Full Text] [Related]

  • 7. Potent siRNA inhibitors of ribonucleotide reductase subunit RRM2 reduce cell proliferation in vitro and in vivo.
    Heidel JD, Liu JY, Yen Y, Zhou B, Heale BS, Rossi JJ, Bartlett DW, Davis ME.
    Clin Cancer Res; 2007 Apr 01; 13(7):2207-15. PubMed ID: 17404105
    [Abstract] [Full Text] [Related]

  • 8. E2F1 promote the aggressiveness of human colorectal cancer by activating the ribonucleotide reductase small subunit M2.
    Fang Z, Gong C, Liu H, Zhang X, Mei L, Song M, Qiu L, Luo S, Zhu Z, Zhang R, Gu H, Chen X.
    Biochem Biophys Res Commun; 2015 Aug 21; 464(2):407-15. PubMed ID: 26093293
    [Abstract] [Full Text] [Related]

  • 9. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
    Zheng HC, Takahashi H, Li XH, Hara T, Masuda S, Guan YF, Takano Y.
    Hum Pathol; 2008 Jul 21; 39(7):1042-9. PubMed ID: 18482745
    [Abstract] [Full Text] [Related]

  • 10. [Expression of Ezrin in gastric carcinoma and its significance].
    Shi RL, Li JF, Qu Y, Chen XH, Gu QL, Zhu ZG, Liu BY.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Sep 21; 9(5):433-5. PubMed ID: 17043968
    [Abstract] [Full Text] [Related]

  • 11. Silencing and CpG island methylation of GSTP1 is rare in ordinary gastric carcinomas but common in Epstein-Barr virus-associated gastric carcinomas.
    Kim J, Lee HS, Bae SI, Lee YM, Kim WH.
    Anticancer Res; 2005 Sep 21; 25(6B):4013-9. PubMed ID: 16309193
    [Abstract] [Full Text] [Related]

  • 12. The prognostic value of ribonucleotide reductase small subunit M2 in predicting recurrence for prostate cancers.
    Huang Y, Liu X, Wang YH, Yeh SD, Chen CL, Nelson RA, Chu P, Wilson T, Yen Y.
    Urol Oncol; 2014 Jan 21; 32(1):51.e9-19. PubMed ID: 24360663
    [Abstract] [Full Text] [Related]

  • 13. Overexpression of catalytic subunit M2 in patients with ovarian cancer.
    Wang LM, Lu FF, Zhang SY, Yao RY, Xing XM, Wei ZM.
    Chin Med J (Engl); 2012 Jun 21; 125(12):2151-6. PubMed ID: 22884145
    [Abstract] [Full Text] [Related]

  • 14. Chemokine receptor CXCR4 expression, function, and clinical implications in gastric cancer.
    Lee HJ, Kim SW, Kim HY, Li S, Yun HJ, Song KS, Kim S, Jo DY.
    Int J Oncol; 2009 Feb 21; 34(2):473-80. PubMed ID: 19148483
    [Abstract] [Full Text] [Related]

  • 15. Expression of integrin-linked kinase is closely correlated with invasion and metastasis of gastric carcinoma.
    Ito R, Oue N, Zhu X, Yoshida K, Nakayama H, Yokozaki H, Yasui W.
    Virchows Arch; 2003 Feb 21; 442(2):118-23. PubMed ID: 12596061
    [Abstract] [Full Text] [Related]

  • 16. Clinicopathologic and biological significance of kallikrein 6 overexpression in human gastric cancer.
    Nagahara H, Mimori K, Utsunomiya T, Barnard GF, Ohira M, Hirakawa K, Mori M.
    Clin Cancer Res; 2005 Oct 01; 11(19 Pt 1):6800-6. PubMed ID: 16203767
    [Abstract] [Full Text] [Related]

  • 17. Survival advantage of EBV-associated gastric carcinoma: survivin up-regulation by viral latent membrane protein 2A.
    Hino R, Uozaki H, Inoue Y, Shintani Y, Ushiku T, Sakatani T, Takada K, Fukayama M.
    Cancer Res; 2008 Mar 01; 68(5):1427-35. PubMed ID: 18316606
    [Abstract] [Full Text] [Related]

  • 18. Cell cycle regulators, APC/beta-catenin, NF-kappaB and Epstein-Barr virus in gastric carcinomas.
    Kim B, Byun SJ, Kim YA, Kim JE, Lee BL, Kim WH, Chang MS.
    Pathology; 2010 Jan 01; 42(1):58-65. PubMed ID: 20025482
    [Abstract] [Full Text] [Related]

  • 19. [Relationship between heparanase mRNA expression in human gastric cancer and its clinicopathological features].
    Chen JQ, Zhan WH, He YL, Peng JS, Wang JP, Chen ZX, Huang YH, Cai SR.
    Zhonghua Zhong Liu Za Zhi; 2004 Oct 01; 26(10):609-11. PubMed ID: 15634522
    [Abstract] [Full Text] [Related]

  • 20. Overexpression of Cullin1 is associated with poor prognosis of patients with gastric cancer.
    Bai J, Zhou Y, Chen G, Zeng J, Ding J, Tan Y, Zhou J, Li G.
    Hum Pathol; 2011 Mar 01; 42(3):375-83. PubMed ID: 21190721
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.